Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling - Concepedia

Concepedia

Publication | Closed Access

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

480

Citations

42

References

2012

Year

Scott Wilkie, May CI van Schalkwyk, Steve Hobbs, David M. Davies, Sjoukje J. C. van der Stegen, Ana C. Parente Pereira, S. Burbridge, Carol Box, Suzanne A. Eccles, John Maher

Journal of Clinical Immunology

Breast OncologyMedicineDual TargetingImmune Checkpoint InhibitorBreast CancerCell BiologyCancer BiologyRadiation OncologyTumor Biology

References

	Year	Citations

Page 1

Page 1